In the third episode of our “Pioneers of Digital Pathology” webinar series, we were honored to host Dr. Santa-Rosario, Chief Medical Officer of CorePlus PR. Dr. Santa-Rosario delves into the intricacies of their validation study, sharing results and offering insights into the shift from manual microscopy to digital diagnostics using Techcyte’s AI platform.
Unprecedented Patient Care: CorePlus Uses AI for 100% QC in Cervical Cytology
Published on January 22, 2024Videos
ArteraAI Announces Research Agreement with CorePlus
ArteraAI, a developer of AI-based cancer tests, has partnered with CorePlus, a CLIA-certified pathology laboratory in Puerto Rico.PublicationsCorePlus leading the way for AI adoption in digital pathology
Watch this interview with CorePlus CEO and CMO to learn why they have chosen to use AI in primary diagnosis.VideosHealth Industry Summit 2024 by the Puerto Rico Manufacturers Association
Mariano de Socarraz, founder and CEO of CorePlus, during the Health Industry Summit 2024 of the Puerto Rico Manufacturers Association.…Events